Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Younger age as a prognostic indicator in breast cancer: a cohort study.

Kheirelseid EH, Boggs JM, Curran C, Glynn RW, Dooley C, Sweeney KJ, Kerin MJ.

BMC Cancer. 2011 Aug 28;11:383. doi: 10.1186/1471-2407-11-383.

2.

Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.

Chen HL, Zhou MQ, Tian W, Meng KX, He HF.

PLoS One. 2016 Oct 31;11(10):e0165409. doi: 10.1371/journal.pone.0165409. eCollection 2016.

3.

Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.

Luyeye Mvila G, Batalansi D, Praet M, Marchal G, Laenen A, Christiaens MR, Brouckaert O, Ali-Risasi C, Neven P, Van Ongeval C.

Breast. 2015 Oct;24(5):642-8. doi: 10.1016/j.breast.2015.07.031. Epub 2015 Aug 14.

PMID:
26279132
4.

Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.

Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, Munsey B, Panella T, Orucevic A.

Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13.

PMID:
23240985
5.

MMP-1 expression has an independent prognostic value in breast cancer.

Boström P, Söderström M, Vahlberg T, Söderström KO, Roberts PJ, Carpén O, Hirsimäki P.

BMC Cancer. 2011 Aug 11;11:348. doi: 10.1186/1471-2407-11-348.

6.

Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.

Madaras L, Baranyák Z, Kulka J, Szász AM, Kovács A, Lan PH, Székely B, Dank M, Nagy T, Kiss O, Harsányi L, Barbai T, Kenessey I, Tőkés AM.

Pathol Oncol Res. 2013 Oct;19(4):723-9. doi: 10.1007/s12253-013-9635-z. Epub 2013 May 26.

PMID:
23709114
7.

Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.

Cherbal F, Gaceb H, Mehemmai C, Saiah I, Bakour R, Rouis AO, Boualga K, Benbrahim W, Mahfouf H.

Breast Dis. 2015;35(2):95-102. doi: 10.3233/BD-150398.

PMID:
25736840
8.

Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.

Rossi V, Nolè F, Redana S, Adamoli L, Martinello R, Aurilio G, Verri E, Sapino A, Viale G, Aglietta M, Montemurro F.

Breast. 2014 Feb;23(1):44-9. doi: 10.1016/j.breast.2013.10.005. Epub 2013 Nov 7.

10.

Stage 0 to stage III breast cancer in young women.

Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST.

J Am Coll Surg. 2000 May;190(5):523-9.

PMID:
10801018
11.

Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis?

Alieldin NH, Abo-Elazm OM, Bilal D, Salem SE, Gouda E, Elmongy M, Ibrahim AS.

J Egypt Natl Canc Inst. 2014 Mar;26(1):23-30. doi: 10.1016/j.jnci.2013.08.005. Epub 2013 Oct 21.

12.

Breast cancer in Chinese women younger than age 40: are they different from their older counterparts?

Kwong A, Cheung P, Chan S, Lau S.

World J Surg. 2008 Dec;32(12):2554-61. doi: 10.1007/s00268-008-9589-6.

PMID:
18408960
13.

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.

Zhou W, Jirström K, Johansson C, Amini RM, Blomqvist C, Agbaje O, Wärnberg F.

BMC Cancer. 2010 Nov 30;10:653. doi: 10.1186/1471-2407-10-653.

14.

Characteristics and prognosis of breast cancer in younger women.

Dirier A, Burhanedtin-Zincircioglu S, Karadayi B, Isikdogan A, Aksu R.

J BUON. 2009 Oct-Dec;14(4):619-23.

PMID:
20148452
15.

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience.

Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, Al Malik O, Alshabanah M, Ezzat A, Al-Tweigeri T.

BMC Cancer. 2007 Dec 5;7:222.

16.

Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study.

Hartley MC, McKinley BP, Rogers EA, Kalbaugh CA, Messich HS, Blackhurst DW, Lokey JS, Trocha SD.

Am Surg. 2006 Dec;72(12):1189-94; discussion 1194-5.

PMID:
17216817
17.

Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.

Kim HJ, Han W, Yi OV, Shin HC, Ahn SK, Koh BS, Moon HG, You JH, Son BH, Ahn SH, Noh DY.

Breast Cancer Res Treat. 2011 Nov;130(2):499-505. doi: 10.1007/s10549-011-1736-3. Epub 2011 Aug 19.

PMID:
21853352
18.

Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?

Agarwal G, Nanda G, Lal P, Mishra A, Agarwal A, Agrawal V, Krishnani N.

World J Surg. 2016 Jun;40(6):1362-72. doi: 10.1007/s00268-016-3422-4.

PMID:
26842691
19.

Supplemental Content

Support Center